02-6180. Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph; Correction  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; correction.

    SUMMARY:

    The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 8, 2002 (67 FR 5942). The document amended the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. The document was inadvertently published with an incorrect docket number. This document corrects that error.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Doris B. Tucker, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

    In FR Doc. 02-3079, appearing on page 5942 in the Federal Register of Friday, February 8, 2002, the following correction is made:

    1. On page 5942, in the first column, “[Docket No. 99N-4063]” is corrected to read “[Docket No. 96P-0460]”.

    Start Signature

    Dated: March 7, 2002.

    Margaret M. Dotzel,

    Associate Commissioner for Policy.

    End Signature End Further Info End Preamble

    [FR Doc. 02-6180 Filed 3-14-02; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
03/15/2002
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
02-6180
Pages:
11571-11571 (1 pages)
Docket Numbers:
Docket No. 96P-0460
PDF File:
02-6180.pdf
CFR: (1)
21 CFR 333